These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28550022)

  • 1. Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study.
    Primavera D; Manchia M; Deriu L; Tusconi M; Collu R; Scherma M; Fadda P; Fratta W; Carpiniello B
    BMJ Open; 2017 May; 7(5):e014938. PubMed ID: 28550022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
    Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
    Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics.
    González-Pinto A; Mosquera F; Palomino A; Alberich S; Gutiérrez A; Haidar K; Vega P; Barbeito S; Ortiz A; Matute C
    Int Clin Psychopharmacol; 2010 Jul; 25(4):241-5. PubMed ID: 20568658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and serum brain-derived neurotrophic factor (BDNF) levels and their association with neurocognition in at-risk mental state, first episode psychosis and chronic schizophrenia patients.
    Heitz U; Papmeyer M; Studerus E; Egloff L; Ittig S; Andreou C; Vogel T; Borgwardt S; Graf M; Eckert A; Riecher-Rössler A
    World J Biol Psychiatry; 2019 Sep; 20(7):545-554. PubMed ID: 29938562
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients.
    Miodownik C; Maayan R; Ratner Y; Lerner V; Pintov L; Mar M; Weizman A; Ritsner MS
    Clin Neuropharmacol; 2011; 34(4):155-60. PubMed ID: 21617527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients.
    Isayeva U; Manchia M; Collu R; Primavera D; Deriu L; Caboni E; Iaselli N; Sundas D; Tusconi M; Pinna F; Paribello P; Scherma M; Pisanu C; Meloni A; Zai CC; Congiu D; Squassina A; Fratta W; Fadda P; Carpiniello B
    Eur Psychiatry; 2022 Oct; 65(1):e71. PubMed ID: 36281033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma Brain-Derived Neurotrophic Factor (BDNF) levels in females with schizophrenia.
    Weickert CS; Lee CH; Lenroot RK; Bruggemann J; Galletly C; Liu D; Balzan R; Pillai A; Buckley P; Weickert TW
    Schizophr Res; 2019 Jul; 209():212-217. PubMed ID: 31088701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data.
    Isayeva U; Manchia M; Collu R; Primavera D; Deriu L; Caboni E; Iaselli NM; Sundas D; Tusconi M; Pinna F; Paribello P; Scherma M; Pisanu C; Meloni A; Zai CC; Congiu D; Squassina A; Fratta W; Fadda P; Carpiniello B
    Schizophr Res; 2024 Apr; 266():197-204. PubMed ID: 38422890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BDNF and S100B in psychotic disorders: evidence for an association with treatment responsiveness.
    van de Kerkhof NW; Fekkes D; van der Heijden FM; Verhoeven WM
    Acta Neuropsychiatr; 2014 Aug; 26(4):223-9. PubMed ID: 25142290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study.
    Wu ZW; Shi H; Chen DC; Chen S; Xiu MH; Zhang XY
    Psychoneuroendocrinology; 2020 Dec; 122():104879. PubMed ID: 33049658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
    Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
    World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower Brain-Derived Neurotropic Factor Levels in Untreated Adolescents With First-Episode Psychosis.
    Şimşek Ş; Gençoğlan S; Yüksel T; Kaplan İ; Aktaş H
    J Clin Psychopharmacol; 2015 Oct; 35(5):596-9. PubMed ID: 26267416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Secondary Analysis of the Complex Interplay between Psychopathology, Cognitive Functions, Brain Derived Neurotrophic Factor Levels, and Suicide in Psychotic Disorders: Data from a 2-Year Longitudinal Study.
    Paribello P; Manchia M; Isayeva U; Upali M; Orrù D; Pinna F; Collu R; Primavera D; Deriu L; Caboni E; Iaselli MN; Sundas D; Tusconi M; Scherma M; Pisanu C; Meloni A; Zai CC; Congiu D; Squassina A; Fratta W; Fadda P; Carpiniello B
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
    Man L; Lv X; Du XD; Yin G; Zhu X; Zhang Y; Soares JC; Yang XN; Chen X; Zhang XY
    Psychiatry Res; 2018 May; 263():1-6. PubMed ID: 29482040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
    Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of Serum Brain-Derived Neurotropic Factor in Individuals at Ultra-High Risk for Psychosis-Findings from the Longitudinal Youth at Risk Study (LYRIKS).
    Yee JY; Lee TS; Lee J
    Int J Neuropsychopharmacol; 2018 Aug; 21(8):734-739. PubMed ID: 29584866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis.
    Huang E; Hettige NC; Zai G; Tomasi J; Huang J; Zai CC; Pivac N; Nikolac Perkovic M; Tiwari AK; Kennedy JL
    Pharmacogenomics J; 2019 Jun; 19(3):269-276. PubMed ID: 30181602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics.
    Chiou YJ; Huang TL
    World J Biol Psychiatry; 2017 Aug; 18(5):382-391. PubMed ID: 27643618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder.
    Dias VV; Brissos S; Frey BN; Andreazza AC; Cardoso C; Kapczinski F
    Bipolar Disord; 2009 Sep; 11(6):663-71. PubMed ID: 19689509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia.
    Jindal RD; Pillai AK; Mahadik SP; Eklund K; Montrose DM; Keshavan MS
    Schizophr Res; 2010 Jun; 119(1-3):47-51. PubMed ID: 20096541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.